| 0 |
BENIGN TRACHEAL NEOPLASM |
1 |
0.2000 |
| 1 |
PREICTAL STATE |
2 |
0.1429 |
| 2 |
BRACHYTHERAPY TO PROSTATE |
1 |
0.0833 |
| 3 |
BARREL CHEST |
1 |
0.0526 |
| 4 |
DIURETIC THERAPY |
2 |
0.0278 |
| 5 |
RIGHT ATRIAL PRESSURE INCREASED |
2 |
0.0247 |
| 6 |
CHRONIC THROAT CLEARING |
1 |
0.0227 |
| 7 |
ALCOHOL TEST POSITIVE |
1 |
0.0213 |
| 8 |
PULMONARY ARTERIAL WEDGE PRESSURE INCREASED |
3 |
0.0172 |
| 9 |
AORTIC BYPASS |
1 |
0.0154 |
| 10 |
MYCOBACTERIUM TEST POSITIVE |
3 |
0.0146 |
| 11 |
ALCOHOL TEST FALSE POSITIVE |
1 |
0.0106 |
| 12 |
RESPIRATORY FATIGUE |
2 |
0.0086 |
| 13 |
BURKHOLDERIA TEST POSITIVE |
1 |
0.0081 |
| 14 |
INCISION SITE DISCHARGE |
2 |
0.0079 |
| 15 |
BREATH SOUNDS |
1 |
0.0073 |
| 16 |
BRONCHOSPASM PARADOXICAL |
2 |
0.0066 |
| 17 |
PACKAGING DESIGN ISSUE |
2 |
0.0061 |
| 18 |
CARDIOACTIVE DRUG LEVEL DECREASED |
1 |
0.0058 |
| 19 |
COR PULMONALE CHRONIC |
1 |
0.0053 |
| 20 |
ACINETOBACTER BACTERAEMIA |
1 |
0.0053 |
| 21 |
BRONCHIAL IRRITATION |
1 |
0.0052 |
| 22 |
DEAFNESS PERMANENT |
1 |
0.0051 |
| 23 |
CONVULSIVE THRESHOLD LOWERED |
2 |
0.0051 |
| 24 |
PROCEDURAL HEADACHE |
2 |
0.0049 |
| 25 |
BENDOPNOEA |
1 |
0.0045 |
| 26 |
ALLERGY TO PLANTS |
2 |
0.0044 |
| 27 |
CONTINUOUS POSITIVE AIRWAY PRESSURE |
1 |
0.0043 |
| 28 |
CORNEAL NEOVASCULARISATION |
1 |
0.0040 |
| 29 |
ADENOTONSILLECTOMY |
1 |
0.0040 |
| 30 |
CHRONIC GASTROINTESTINAL BLEEDING |
1 |
0.0039 |
| 31 |
CATHETERISATION CARDIAC ABNORMAL |
1 |
0.0037 |
| 32 |
OXYGEN CONSUMPTION INCREASED |
8 |
0.0033 |
| 33 |
LIQUID PRODUCT PHYSICAL ISSUE |
24 |
0.0033 |
| 34 |
CARBON DIOXIDE ABNORMAL |
1 |
0.0032 |
| 35 |
COR PULMONALE |
3 |
0.0031 |
| 36 |
CONDUCTIVE DEAFNESS |
1 |
0.0031 |
| 37 |
CUBITAL TUNNEL SYNDROME |
1 |
0.0029 |
| 38 |
PRODUCT CLOSURE REMOVAL DIFFICULT |
3 |
0.0029 |
| 39 |
BONE MARROW OEDEMA |
3 |
0.0029 |
| 40 |
ASTHMA EXERCISE INDUCED |
1 |
0.0029 |
| 41 |
ALANINE AMINOTRANSFERASE DECREASED |
2 |
0.0028 |
| 42 |
INFUSION SITE MASS |
3 |
0.0028 |
| 43 |
CAPILLARY DISORDER |
1 |
0.0026 |
| 44 |
DEPENDENCE ON RESPIRATOR |
1 |
0.0025 |
| 45 |
POST-TRAUMATIC NECK SYNDROME |
2 |
0.0025 |
| 46 |
DEATH OF RELATIVE |
1 |
0.0025 |
| 47 |
SPUTUM CULTURE POSITIVE |
2 |
0.0025 |
| 48 |
INFUSION SITE OEDEMA |
2 |
0.0024 |
| 49 |
PRODUCT TASTE ABNORMAL |
32 |
0.0024 |
| 50 |
BRONCHIAL SECRETION RETENTION |
3 |
0.0024 |
| 51 |
EOSINOPHILIC PNEUMONIA ACUTE |
2 |
0.0023 |
| 52 |
ANAEMIA OF CHRONIC DISEASE |
2 |
0.0022 |
| 53 |
CIRRHOSIS ALCOHOLIC |
1 |
0.0022 |
| 54 |
RHONCHI |
3 |
0.0022 |
| 55 |
SPUTUM RETENTION |
2 |
0.0020 |
| 56 |
CORNEAL SCAR |
1 |
0.0020 |
| 57 |
PRODUCT MEASURED POTENCY ISSUE |
2 |
0.0020 |
| 58 |
RESPIRATORY TRACT IRRITATION |
2 |
0.0019 |
| 59 |
ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME |
1 |
0.0019 |
| 60 |
BONE DEMINERALISATION |
2 |
0.0019 |
| 61 |
OXYGEN SATURATION ABNORMAL |
5 |
0.0018 |
| 62 |
BURN ORAL CAVITY |
1 |
0.0017 |
| 63 |
CARBON DIOXIDE DECREASED |
2 |
0.0017 |
| 64 |
PRODUCT CONTAMINATION MICROBIAL |
2 |
0.0017 |
| 65 |
COCCIDIOIDOMYCOSIS |
2 |
0.0017 |
| 66 |
CHRONIC RESPIRATORY FAILURE |
2 |
0.0017 |
| 67 |
SUSPECTED PRODUCT QUALITY ISSUE |
3 |
0.0016 |
| 68 |
BACILLUS INFECTION |
1 |
0.0016 |
| 69 |
ACTIVITIES OF DAILY LIVING DECREASED |
1 |
0.0016 |
| 70 |
ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC |
1 |
0.0015 |
| 71 |
LIP EXFOLIATION |
2 |
0.0015 |
| 72 |
CATARACT NUCLEAR |
1 |
0.0015 |
| 73 |
ACUTE LEFT VENTRICULAR FAILURE |
1 |
0.0015 |
| 74 |
POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME |
2 |
0.0015 |
| 75 |
CONTRAINDICATED DRUG ADMINISTERED |
1 |
0.0014 |
| 76 |
STAPHYLOCOCCUS TEST POSITIVE |
3 |
0.0014 |
| 77 |
PHARYNGEAL ERYTHEMA |
3 |
0.0014 |
| 78 |
CERVICAL RADICULOPATHY |
1 |
0.0014 |
| 79 |
BRONCHIAL WALL THICKENING |
1 |
0.0014 |
| 80 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
72 |
0.0014 |
| 81 |
APALLIC SYNDROME |
1 |
0.0014 |
| 82 |
BACTERIAL DISEASE CARRIER |
1 |
0.0014 |
| 83 |
ACCOMMODATION DISORDER |
1 |
0.0014 |
| 84 |
ATROPHIC VULVOVAGINITIS |
1 |
0.0014 |
| 85 |
INTENTIONAL DEVICE MISUSE |
6 |
0.0014 |
| 86 |
TOBACCO USER |
2 |
0.0013 |
| 87 |
INFUSION SITE REACTION |
4 |
0.0013 |
| 88 |
ASPIRATION PLEURAL CAVITY |
1 |
0.0013 |
| 89 |
INFUSION SITE INFECTION |
3 |
0.0013 |
| 90 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
7 |
0.0013 |
| 91 |
INFUSION SITE PRURITUS |
4 |
0.0013 |
| 92 |
CYSTIC FIBROSIS |
7 |
0.0013 |
| 93 |
PNEUMONIA VIRAL |
4 |
0.0013 |
| 94 |
ALLERGIC GRANULOMATOUS ANGIITIS |
1 |
0.0012 |
| 95 |
OXYGEN THERAPY |
2 |
0.0012 |
| 96 |
SUFFOCATION FEELING |
3 |
0.0012 |
| 97 |
BRONCHIECTASIS |
8 |
0.0012 |
| 98 |
LOWER RESPIRATORY TRACT CONGESTION |
2 |
0.0012 |
| 99 |
INCREASED BRONCHIAL SECRETION |
3 |
0.0012 |
| 100 |
PRODUCT PACKAGING DIFFICULT TO OPEN |
3 |
0.0011 |
| 101 |
INFUSION SITE DISCHARGE |
2 |
0.0011 |
| 102 |
CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION |
1 |
0.0011 |
| 103 |
CALCIPHYLAXIS |
2 |
0.0011 |
| 104 |
ORAL DISCOMFORT |
15 |
0.0011 |
| 105 |
FORCED EXPIRATORY VOLUME DECREASED |
3 |
0.0011 |
| 106 |
SKIN ABRASION |
5 |
0.0011 |
| 107 |
LIP DISORDER |
2 |
0.0011 |
| 108 |
ADRENAL DISORDER |
2 |
0.0010 |
| 109 |
TRAUMATIC LUNG INJURY |
2 |
0.0010 |
| 110 |
NASAL SEPTUM DEVIATION |
2 |
0.0010 |
| 111 |
JOINT NOISE |
2 |
0.0010 |
| 112 |
RESPIRATION ABNORMAL |
7 |
0.0010 |
| 113 |
PRODUCT COLOUR ISSUE |
5 |
0.0010 |
| 114 |
CONJUNCTIVAL OEDEMA |
1 |
0.0010 |
| 115 |
ACUTE PROMYELOCYTIC LEUKAEMIA |
1 |
0.0010 |
| 116 |
ALVEOLITIS ALLERGIC |
1 |
0.0010 |
| 117 |
INCORRECT DRUG ADMINISTRATION RATE |
4 |
0.0009 |
| 118 |
SPUTUM INCREASED |
2 |
0.0009 |
| 119 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
5 |
0.0009 |
| 120 |
CRYPTORCHISM |
1 |
0.0009 |
| 121 |
GASTROINTESTINAL HYPOMOTILITY |
2 |
0.0009 |
| 122 |
COMPUTERISED TOMOGRAM ABNORMAL |
2 |
0.0009 |
| 123 |
RESPIRATORY TRACT INFECTION |
23 |
0.0009 |
| 124 |
CERVICAL VERTEBRAL FRACTURE |
3 |
0.0009 |
| 125 |
MOUTH SWELLING |
5 |
0.0009 |
| 126 |
ACUTE PRERENAL FAILURE |
1 |
0.0009 |
| 127 |
AORTIC STENOSIS |
3 |
0.0009 |
| 128 |
NECK SURGERY |
2 |
0.0009 |
| 129 |
RIGHT VENTRICULAR FAILURE |
6 |
0.0009 |
| 130 |
LUNG TRANSPLANT |
3 |
0.0008 |
| 131 |
SINUS OPERATION |
2 |
0.0008 |
| 132 |
ACUTE RESPIRATORY FAILURE |
16 |
0.0008 |
| 133 |
PRODUCT PACKAGING CONFUSION |
2 |
0.0008 |
| 134 |
PRODUCTIVE COUGH |
39 |
0.0008 |
| 135 |
DERMAL CYST |
2 |
0.0008 |
| 136 |
BREATH SOUNDS ABNORMAL |
4 |
0.0008 |
| 137 |
HYPOXIA |
28 |
0.0008 |
| 138 |
INFUSION SITE SWELLING |
5 |
0.0008 |
| 139 |
DACRYOSTENOSIS ACQUIRED |
1 |
0.0008 |
| 140 |
THERAPEUTIC PRODUCT EFFECT VARIABLE |
3 |
0.0008 |
| 141 |
LIPOMA |
2 |
0.0008 |
| 142 |
HERNIA REPAIR |
2 |
0.0008 |
| 143 |
ABDOMINAL OPERATION |
1 |
0.0008 |
| 144 |
ADJUSTMENT DISORDER |
1 |
0.0008 |
| 145 |
RETINAL DISORDER |
2 |
0.0008 |
| 146 |
ANAEMIA POSTOPERATIVE |
1 |
0.0008 |
| 147 |
PRODUCT ADMINISTRATION INTERRUPTED |
6 |
0.0008 |
| 148 |
ACROCHORDON |
1 |
0.0008 |
| 149 |
OBSTRUCTION |
3 |
0.0008 |
| 150 |
ANION GAP INCREASED |
1 |
0.0007 |
| 151 |
CANDIDIASIS |
3 |
0.0007 |
| 152 |
BODY MASS INDEX INCREASED |
1 |
0.0007 |
| 153 |
DYSGEUSIA |
55 |
0.0007 |
| 154 |
PRODUCT PACKAGING ISSUE |
7 |
0.0007 |
| 155 |
DECUBITUS ULCER |
6 |
0.0007 |
| 156 |
MIGRAINE WITH AURA |
2 |
0.0007 |
| 157 |
PERIPHERAL VENOUS DISEASE |
3 |
0.0007 |
| 158 |
CALCULUS BLADDER |
1 |
0.0007 |
| 159 |
SECRETION DISCHARGE |
9 |
0.0007 |
| 160 |
HEART RATE ABNORMAL |
4 |
0.0007 |
| 161 |
TONGUE DISCOMFORT |
3 |
0.0007 |
| 162 |
SEASONAL ALLERGY |
10 |
0.0007 |
| 163 |
AUDITORY DISORDER |
1 |
0.0007 |
| 164 |
JOINT LOCK |
2 |
0.0007 |
| 165 |
DYSPNOEA AT REST |
2 |
0.0007 |
| 166 |
RALES |
4 |
0.0007 |
| 167 |
STRIDOR |
2 |
0.0007 |
| 168 |
COCCYDYNIA |
1 |
0.0007 |
| 169 |
AXILLARY PAIN |
1 |
0.0007 |
| 170 |
PRODUCT ODOUR ABNORMAL |
7 |
0.0007 |
| 171 |
HYPERCAPNIA |
2 |
0.0007 |
| 172 |
ADHESION |
1 |
0.0007 |
| 173 |
EXPIRED PRODUCT ADMINISTERED |
22 |
0.0007 |
| 174 |
VASCULAR DEVICE INFECTION |
3 |
0.0007 |
| 175 |
ECONOMIC PROBLEM |
10 |
0.0007 |
| 176 |
EMERGENCY CARE |
2 |
0.0007 |
| 177 |
ABDOMINAL HERNIA |
3 |
0.0007 |
| 178 |
SKIN LACERATION |
7 |
0.0006 |
| 179 |
INFUSION SITE EXTRAVASATION |
4 |
0.0006 |
| 180 |
PRE-EXISTING CONDITION IMPROVED |
4 |
0.0006 |
| 181 |
BLOOD CREATININE DECREASED |
2 |
0.0006 |
| 182 |
RESPIRATORY RATE DECREASED |
2 |
0.0006 |
| 183 |
PULMONARY HYPERTENSION |
13 |
0.0006 |
| 184 |
GLAUCOMA |
12 |
0.0006 |
| 185 |
HAEMOGLOBIN ABNORMAL |
4 |
0.0006 |
| 186 |
INFUSION SITE PAIN |
8 |
0.0006 |
| 187 |
RHINITIS |
5 |
0.0006 |
| 188 |
DYSPNOEA EXERTIONAL |
23 |
0.0006 |
| 189 |
INFUSION SITE HAEMORRHAGE |
2 |
0.0006 |
| 190 |
OXYGEN SATURATION DECREASED |
34 |
0.0006 |
| 191 |
ASTHMA |
68 |
0.0006 |
| 192 |
BLOOD CALCIUM ABNORMAL |
1 |
0.0006 |
| 193 |
ARTHROPOD STING |
1 |
0.0006 |
| 194 |
ANXIETY DISORDER |
2 |
0.0006 |
| 195 |
POTENTIATING DRUG INTERACTION |
2 |
0.0006 |
| 196 |
OSTEOPENIA |
9 |
0.0006 |
| 197 |
TOXIC ENCEPHALOPATHY |
3 |
0.0006 |
| 198 |
INSURANCE ISSUE |
9 |
0.0006 |
| 199 |
DEAFNESS BILATERAL |
1 |
0.0006 |
| 200 |
TACHYPNOEA |
8 |
0.0006 |
| 201 |
EAR DISCOMFORT |
6 |
0.0006 |
| 202 |
LEFT VENTRICULAR FAILURE |
2 |
0.0006 |
| 203 |
ACUTE SINUSITIS |
1 |
0.0006 |
| 204 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
5 |
0.0006 |
| 205 |
APHONIA |
8 |
0.0006 |
| 206 |
TYPE I HYPERSENSITIVITY |
2 |
0.0006 |
| 207 |
DYSPHONIA |
33 |
0.0006 |
| 208 |
THERMAL BURN |
4 |
0.0006 |
| 209 |
PRODUCT CONTAMINATION |
2 |
0.0006 |
| 210 |
BODY HEIGHT DECREASED |
6 |
0.0006 |
| 211 |
AORTIC VALVE STENOSIS |
1 |
0.0006 |
| 212 |
COMPRESSION FRACTURE |
3 |
0.0006 |
| 213 |
IMPAIRED QUALITY OF LIFE |
8 |
0.0006 |
| 214 |
CHEILITIS |
3 |
0.0006 |
| 215 |
PULMONARY ARTERIAL HYPERTENSION |
8 |
0.0006 |
| 216 |
SCLERODERMA |
2 |
0.0005 |
| 217 |
DENTAL CARIES |
6 |
0.0005 |
| 218 |
HYPERACUSIS |
2 |
0.0005 |
| 219 |
BLOOD CHOLESTEROL DECREASED |
1 |
0.0005 |
| 220 |
BLADDER SPASM |
1 |
0.0005 |
| 221 |
ORAL CANDIDIASIS |
7 |
0.0005 |
| 222 |
WHEEZING |
31 |
0.0005 |
| 223 |
OESOPHAGEAL ULCER |
2 |
0.0005 |
| 224 |
NERVOUSNESS |
27 |
0.0005 |
| 225 |
REHABILITATION THERAPY |
2 |
0.0005 |
| 226 |
ELECTROLYTE IMBALANCE |
6 |
0.0005 |
| 227 |
STRESS CARDIOMYOPATHY |
3 |
0.0005 |
| 228 |
RHINOVIRUS INFECTION |
2 |
0.0005 |
| 229 |
ORAL INFECTION |
2 |
0.0005 |
| 230 |
MULTIPLE ALLERGIES |
4 |
0.0005 |
| 231 |
PROSTATOMEGALY |
2 |
0.0005 |
| 232 |
PNEUMONIA FUNGAL |
2 |
0.0005 |
| 233 |
HOSPICE CARE |
5 |
0.0005 |
| 234 |
POLYDIPSIA |
2 |
0.0005 |
| 235 |
SUSPECTED COUNTERFEIT PRODUCT |
2 |
0.0005 |
| 236 |
RESPIRATORY TRACT CONGESTION |
8 |
0.0005 |
| 237 |
HAEMOPTYSIS |
14 |
0.0005 |
| 238 |
CEREBRAL ATROPHY |
2 |
0.0005 |
| 239 |
SQUAMOUS CELL CARCINOMA OF SKIN |
3 |
0.0005 |
| 240 |
EMPHYSEMA |
5 |
0.0005 |
| 241 |
FUNGAL SKIN INFECTION |
2 |
0.0005 |
| 242 |
DRY THROAT |
5 |
0.0005 |
| 243 |
DYSPNOEA |
278 |
0.0005 |
| 244 |
UPPER-AIRWAY COUGH SYNDROME |
4 |
0.0005 |
| 245 |
SPINAL COMPRESSION FRACTURE |
4 |
0.0005 |
| 246 |
FLUID OVERLOAD |
7 |
0.0005 |
| 247 |
INFUSION SITE ERYTHEMA |
4 |
0.0005 |
| 248 |
POOR QUALITY PRODUCT ADMINISTERED |
5 |
0.0005 |
| 249 |
BRONCHITIS |
35 |
0.0005 |
| 250 |
WHITE BLOOD CELL COUNT ABNORMAL |
3 |
0.0005 |
| 251 |
INTERVERTEBRAL DISC DISORDER |
2 |
0.0005 |
| 252 |
C-REACTIVE PROTEIN ABNORMAL |
3 |
0.0005 |
| 253 |
PSEUDOMONAS INFECTION |
4 |
0.0005 |
| 254 |
DEVICE OPERATIONAL ISSUE |
2 |
0.0005 |
| 255 |
AMYOTROPHIC LATERAL SCLEROSIS |
1 |
0.0005 |
| 256 |
CHOKING |
9 |
0.0005 |
| 257 |
STAPHYLOCOCCAL BACTERAEMIA |
2 |
0.0005 |
| 258 |
PULMONARY FUNCTION TEST DECREASED |
2 |
0.0005 |
| 259 |
ACCIDENT AT WORK |
1 |
0.0005 |
| 260 |
CATHETERISATION CARDIAC |
2 |
0.0005 |
| 261 |
IMPLANT SITE PAIN |
2 |
0.0004 |
| 262 |
CORNEAL OEDEMA |
1 |
0.0004 |
| 263 |
SINUS CONGESTION |
6 |
0.0004 |
| 264 |
BLOOD LOSS ANAEMIA |
1 |
0.0004 |
| 265 |
ABNORMAL LOSS OF WEIGHT |
3 |
0.0004 |
| 266 |
URINE ABNORMALITY |
2 |
0.0004 |
| 267 |
BLOOD PRESSURE SYSTOLIC DECREASED |
2 |
0.0004 |
| 268 |
DISEASE COMPLICATION |
2 |
0.0004 |
| 269 |
PNEUMONIA BACTERIAL |
4 |
0.0004 |
| 270 |
EYE OPERATION |
2 |
0.0004 |
| 271 |
LYMPHOEDEMA |
3 |
0.0004 |
| 272 |
NEPHROGENIC ANAEMIA |
2 |
0.0004 |
| 273 |
ARTHRITIS INFECTIVE |
2 |
0.0004 |
| 274 |
RENAL FUNCTION TEST ABNORMAL |
2 |
0.0004 |
| 275 |
ROSACEA |
2 |
0.0004 |
| 276 |
STAPHYLOCOCCAL INFECTION |
14 |
0.0004 |
| 277 |
SPUTUM DISCOLOURED |
4 |
0.0004 |
| 278 |
BACTERAEMIA |
5 |
0.0004 |
| 279 |
FUNGAL INFECTION |
14 |
0.0004 |
| 280 |
MEDICATION RESIDUE PRESENT |
2 |
0.0004 |
| 281 |
SUPRAVENTRICULAR TACHYCARDIA |
4 |
0.0004 |
| 282 |
NON-SMALL CELL LUNG CANCER |
2 |
0.0004 |
| 283 |
WRIST FRACTURE |
5 |
0.0004 |
| 284 |
TUMOUR MARKER INCREASED |
2 |
0.0004 |
| 285 |
BLOOD IMMUNOGLOBULIN E INCREASED |
1 |
0.0004 |
| 286 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
7 |
0.0004 |
| 287 |
UPPER RESPIRATORY TRACT INFECTION |
19 |
0.0004 |
| 288 |
BREATH ODOUR |
1 |
0.0004 |
| 289 |
BRONCHITIS CHRONIC |
1 |
0.0004 |
| 290 |
HYPERVOLAEMIA |
2 |
0.0004 |
| 291 |
BLOOD IMMUNOGLOBULIN G DECREASED |
1 |
0.0004 |
| 292 |
PULMONARY MASS |
6 |
0.0004 |
| 293 |
BLOOD PRESSURE ABNORMAL |
8 |
0.0004 |
| 294 |
THROAT IRRITATION |
18 |
0.0004 |
| 295 |
CATHETER SITE HAEMORRHAGE |
1 |
0.0004 |
| 296 |
OROPHARYNGEAL PAIN |
37 |
0.0004 |
| 297 |
COUGH |
112 |
0.0004 |
| 298 |
PAROSMIA |
3 |
0.0004 |
| 299 |
CANCER PAIN |
1 |
0.0004 |
| 300 |
RENAL FAILURE CHRONIC |
3 |
0.0004 |
| 301 |
BLOOD CHLORIDE DECREASED |
1 |
0.0004 |
| 302 |
GASTROENTERITIS VIRAL |
7 |
0.0004 |
| 303 |
TRISMUS |
2 |
0.0004 |
| 304 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
3 |
0.0004 |
| 305 |
FAILURE TO THRIVE |
2 |
0.0004 |
| 306 |
COMPARTMENT SYNDROME |
1 |
0.0004 |
| 307 |
WEIGHT FLUCTUATION |
4 |
0.0004 |
| 308 |
TRANSFUSION |
4 |
0.0004 |
| 309 |
SENSITIVITY TO WEATHER CHANGE |
2 |
0.0004 |
| 310 |
PULMONARY CONGESTION |
5 |
0.0004 |
| 311 |
HEAD INJURY |
12 |
0.0004 |
| 312 |
NYSTAGMUS |
2 |
0.0004 |
| 313 |
PRODUCT RESIDUE PRESENT |
2 |
0.0004 |
| 314 |
BLOOD SODIUM INCREASED |
1 |
0.0004 |
| 315 |
BACK DISORDER |
6 |
0.0004 |
| 316 |
BACK INJURY |
4 |
0.0004 |
| 317 |
FEELING JITTERY |
7 |
0.0004 |
| 318 |
IMPAIRED GASTRIC EMPTYING |
5 |
0.0004 |
| 319 |
ASPIRATION |
4 |
0.0004 |
| 320 |
PNEUMONIA |
118 |
0.0004 |
| 321 |
GASTROINTESTINAL PAIN |
4 |
0.0004 |
| 322 |
CHOKING SENSATION |
2 |
0.0004 |
| 323 |
PROSTATIC DISORDER |
2 |
0.0004 |
| 324 |
OBSTRUCTIVE AIRWAYS DISORDER |
4 |
0.0004 |
| 325 |
NASAL CONGESTION |
21 |
0.0004 |
| 326 |
SENSATION OF FOREIGN BODY |
3 |
0.0004 |
| 327 |
EYE INFECTION |
4 |
0.0004 |
| 328 |
SINUS DISORDER |
7 |
0.0004 |
| 329 |
PAIN IN JAW |
10 |
0.0004 |
| 330 |
BRONCHOSPASM |
5 |
0.0004 |
| 331 |
MUSCULOSKELETAL DISCOMFORT |
6 |
0.0003 |
| 332 |
BLOOD MAGNESIUM DECREASED |
3 |
0.0003 |
| 333 |
CARDIAC MURMUR |
3 |
0.0003 |
| 334 |
PRODUCT QUALITY ISSUE |
47 |
0.0003 |
| 335 |
URINE OUTPUT DECREASED |
3 |
0.0003 |
| 336 |
PRODUCT LABEL CONFUSION |
2 |
0.0003 |
| 337 |
RIB FRACTURE |
7 |
0.0003 |
| 338 |
LUNG INFILTRATION |
3 |
0.0003 |
| 339 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
3 |
0.0003 |
| 340 |
SINUS HEADACHE |
2 |
0.0003 |
| 341 |
GASTROINTESTINAL INFECTION |
3 |
0.0003 |
| 342 |
HEARING IMPAIRED |
2 |
0.0003 |
| 343 |
GANGRENE |
2 |
0.0003 |
| 344 |
LIP SWELLING |
11 |
0.0003 |
| 345 |
RESTLESS LEGS SYNDROME |
6 |
0.0003 |
| 346 |
DEVICE DELIVERY SYSTEM ISSUE |
9 |
0.0003 |
| 347 |
DEVICE FAILURE |
5 |
0.0003 |
| 348 |
CHEST X-RAY ABNORMAL |
1 |
0.0003 |
| 349 |
RESPIRATORY DISTRESS |
9 |
0.0003 |
| 350 |
IRON DEFICIENCY ANAEMIA |
3 |
0.0003 |
| 351 |
BRAIN NATRIURETIC PEPTIDE INCREASED |
1 |
0.0003 |
| 352 |
CONCOMITANT DISEASE AGGRAVATED |
2 |
0.0003 |
| 353 |
LUNG INFECTION |
5 |
0.0003 |
| 354 |
FLANK PAIN |
3 |
0.0003 |
| 355 |
ARTERIOSCLEROSIS |
3 |
0.0003 |
| 356 |
ABDOMINAL ADHESIONS |
1 |
0.0003 |
| 357 |
BLADDER PAIN |
1 |
0.0003 |
| 358 |
SLEEP APNOEA SYNDROME |
6 |
0.0003 |
| 359 |
SCIATICA |
5 |
0.0003 |
| 360 |
PROCTALGIA |
2 |
0.0003 |
| 361 |
ATELECTASIS |
3 |
0.0003 |
| 362 |
CARDIAC FLUTTER |
2 |
0.0003 |
| 363 |
DRY MOUTH |
25 |
0.0003 |
| 364 |
VITAMIN D DEFICIENCY |
3 |
0.0003 |
| 365 |
TREMOR |
51 |
0.0003 |
| 366 |
PHARYNGEAL SWELLING |
3 |
0.0003 |
| 367 |
THERAPY CHANGE |
3 |
0.0003 |
| 368 |
ANHEDONIA |
8 |
0.0003 |
| 369 |
LIGAMENT SPRAIN |
3 |
0.0003 |
| 370 |
WALKING AID USER |
2 |
0.0003 |
| 371 |
PRODUCT FORMULATION ISSUE |
2 |
0.0003 |
| 372 |
SINUSITIS |
31 |
0.0003 |
| 373 |
INABILITY TO AFFORD MEDICATION |
3 |
0.0003 |
| 374 |
RESPIRATORY FAILURE |
22 |
0.0003 |
| 375 |
BLOOD POTASSIUM DECREASED |
9 |
0.0003 |
| 376 |
CANDIDA INFECTION |
5 |
0.0003 |
| 377 |
WRONG PRODUCT ADMINISTERED |
2 |
0.0003 |
| 378 |
FLUID RETENTION |
15 |
0.0003 |
| 379 |
PRODUCT LABEL ISSUE |
2 |
0.0003 |
| 380 |
SLUGGISHNESS |
3 |
0.0003 |
| 381 |
RHINORRHOEA |
19 |
0.0003 |
| 382 |
CHEST DISCOMFORT |
30 |
0.0003 |
| 383 |
JOINT EFFUSION |
2 |
0.0003 |
| 384 |
BLOOD CREATININE ABNORMAL |
1 |
0.0003 |
| 385 |
MENTAL STATUS CHANGES |
8 |
0.0003 |
| 386 |
FORMICATION |
2 |
0.0003 |
| 387 |
PERIPHERAL SWELLING |
44 |
0.0003 |
| 388 |
SCRATCH |
3 |
0.0003 |
| 389 |
BRONCHIOLITIS |
1 |
0.0003 |
| 390 |
HEAD DISCOMFORT |
5 |
0.0003 |
| 391 |
DIVERTICULUM |
2 |
0.0003 |
| 392 |
RETCHING |
6 |
0.0003 |
| 393 |
AGEUSIA |
7 |
0.0003 |
| 394 |
DECREASED ACTIVITY |
3 |
0.0003 |
| 395 |
LACTIC ACIDOSIS |
9 |
0.0003 |
| 396 |
ASTHMATIC CRISIS |
1 |
0.0003 |
| 397 |
MAJOR DEPRESSION |
2 |
0.0003 |
| 398 |
BLOOD PRESSURE DIASTOLIC DECREASED |
2 |
0.0003 |
| 399 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
2 |
0.0003 |
| 400 |
CEREBRAL DISORDER |
2 |
0.0003 |
| 401 |
CHEST PAIN |
50 |
0.0003 |
| 402 |
CONJUNCTIVITIS |
5 |
0.0003 |
| 403 |
CARDIAC DYSFUNCTION |
1 |
0.0003 |
| 404 |
IMMUNODEFICIENCY |
4 |
0.0003 |
| 405 |
GLOSSODYNIA |
6 |
0.0003 |
| 406 |
INTESTINAL PERFORATION |
3 |
0.0003 |
| 407 |
HYPOAESTHESIA ORAL |
4 |
0.0003 |
| 408 |
MITRAL VALVE INCOMPETENCE |
3 |
0.0003 |
| 409 |
URINARY TRACT INFECTION |
45 |
0.0003 |
| 410 |
BLOOD URINE PRESENT |
5 |
0.0003 |
| 411 |
DERMATITIS CONTACT |
3 |
0.0003 |
| 412 |
COMMUNICATION DISORDER |
1 |
0.0003 |
| 413 |
PULMONARY FIBROSIS |
5 |
0.0003 |
| 414 |
PHARYNGEAL OEDEMA |
4 |
0.0003 |
| 415 |
DRUG EFFECT DECREASED |
14 |
0.0003 |
| 416 |
THYROID DISORDER |
4 |
0.0003 |
| 417 |
FOOD ALLERGY |
2 |
0.0003 |
| 418 |
CONCUSSION |
2 |
0.0003 |
| 419 |
SWOLLEN TONGUE |
8 |
0.0003 |
| 420 |
OEDEMA PERIPHERAL |
31 |
0.0003 |
| 421 |
EPISTAXIS |
19 |
0.0003 |
| 422 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
5 |
0.0003 |
| 423 |
FURUNCLE |
2 |
0.0003 |
| 424 |
HEART RATE INCREASED |
25 |
0.0003 |
| 425 |
CHOLECYSTITIS |
3 |
0.0003 |
| 426 |
ULCER |
4 |
0.0003 |
| 427 |
MACULAR DEGENERATION |
3 |
0.0003 |
| 428 |
OBESITY |
4 |
0.0003 |
| 429 |
AZOTAEMIA |
1 |
0.0003 |
| 430 |
CREATININE RENAL CLEARANCE DECREASED |
1 |
0.0002 |
| 431 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
12 |
0.0002 |
| 432 |
HIP FRACTURE |
8 |
0.0002 |
| 433 |
VISION BLURRED |
34 |
0.0002 |
| 434 |
MYASTHENIA GRAVIS |
2 |
0.0002 |
| 435 |
MUSCLE TIGHTNESS |
4 |
0.0002 |
| 436 |
TASTE DISORDER |
5 |
0.0002 |
| 437 |
BLOOD POTASSIUM INCREASED |
4 |
0.0002 |
| 438 |
POST PROCEDURAL INFECTION |
2 |
0.0002 |
| 439 |
DYSURIA |
9 |
0.0002 |
| 440 |
GLOMERULAR FILTRATION RATE DECREASED |
3 |
0.0002 |
| 441 |
ABNORMAL FAECES |
2 |
0.0002 |
| 442 |
TENDON RUPTURE |
3 |
0.0002 |
| 443 |
PHARYNGITIS |
3 |
0.0002 |
| 444 |
ILEUS |
3 |
0.0002 |
| 445 |
DRY EYE |
12 |
0.0002 |
| 446 |
ACCIDENTAL EXPOSURE |
1 |
0.0002 |
| 447 |
EOSINOPHIL COUNT INCREASED |
2 |
0.0002 |
| 448 |
INTESTINAL OBSTRUCTION |
9 |
0.0002 |
| 449 |
EYE PRURITUS |
8 |
0.0002 |
| 450 |
CATARACT |
14 |
0.0002 |
| 451 |
AORTIC VALVE INCOMPETENCE |
1 |
0.0002 |
| 452 |
CARDIAC FAILURE CHRONIC |
1 |
0.0002 |
| 453 |
FACIAL PARALYSIS |
2 |
0.0002 |
| 454 |
RESPIRATORY DISORDER |
7 |
0.0002 |
| 455 |
VITAMIN D DECREASED |
2 |
0.0002 |
| 456 |
MYDRIASIS |
3 |
0.0002 |
| 457 |
ROTATOR CUFF SYNDROME |
3 |
0.0002 |
| 458 |
PRODUCT CONTAINER ISSUE |
2 |
0.0002 |
| 459 |
IRRITABLE BOWEL SYNDROME |
5 |
0.0002 |
| 460 |
INFLUENZA |
26 |
0.0002 |
| 461 |
DYSPHAGIA |
22 |
0.0002 |
| 462 |
ATRIOVENTRICULAR BLOCK FIRST DEGREE |
1 |
0.0002 |
| 463 |
CHAPPED LIPS |
1 |
0.0002 |
| 464 |
BONE CANCER |
1 |
0.0002 |
| 465 |
INTERVERTEBRAL DISC PROTRUSION |
5 |
0.0002 |
| 466 |
BLOOD CREATINE INCREASED |
1 |
0.0002 |
| 467 |
RESPIRATORY RATE INCREASED |
2 |
0.0002 |
| 468 |
LUNG DISORDER |
11 |
0.0002 |
| 469 |
JOINT RANGE OF MOTION DECREASED |
3 |
0.0002 |
| 470 |
QUALITY OF LIFE DECREASED |
3 |
0.0002 |
| 471 |
ILLNESS |
23 |
0.0002 |
| 472 |
SNEEZING |
5 |
0.0002 |
| 473 |
END STAGE RENAL DISEASE |
4 |
0.0002 |
| 474 |
OSTEOPOROSIS |
9 |
0.0002 |
| 475 |
PRODUCT USE IN UNAPPROVED INDICATION |
54 |
0.0002 |
| 476 |
INTENTIONAL PRODUCT MISUSE |
19 |
0.0002 |
| 477 |
BLOOD CHOLESTEROL ABNORMAL |
1 |
0.0002 |
| 478 |
POLLAKIURIA |
9 |
0.0002 |
| 479 |
PRODUCT DISTRIBUTION ISSUE |
2 |
0.0002 |
| 480 |
ROAD TRAFFIC ACCIDENT |
9 |
0.0002 |
| 481 |
BACTERIAL INFECTION |
4 |
0.0002 |
| 482 |
LEUKAEMIA |
2 |
0.0002 |
| 483 |
PRODUCT DOSE OMISSION IN ERROR |
6 |
0.0002 |
| 484 |
CARDIAC FAILURE CONGESTIVE |
17 |
0.0002 |
| 485 |
RECALLED PRODUCT ADMINISTERED |
2 |
0.0002 |
| 486 |
POST PROCEDURAL COMPLICATION |
4 |
0.0002 |
| 487 |
LOWER LIMB FRACTURE |
4 |
0.0002 |
| 488 |
TRANSIENT ISCHAEMIC ATTACK |
7 |
0.0002 |
| 489 |
ANOSMIA |
3 |
0.0002 |
| 490 |
HERNIA |
4 |
0.0002 |
| 491 |
LOCALISED INFECTION |
5 |
0.0002 |
| 492 |
PRESYNCOPE |
5 |
0.0002 |
| 493 |
NEURALGIA |
5 |
0.0002 |
| 494 |
GASTROENTERITIS |
3 |
0.0002 |
| 495 |
HEPATOMEGALY |
2 |
0.0002 |
| 496 |
VITREOUS FLOATERS |
2 |
0.0002 |
| 497 |
OEDEMA |
11 |
0.0002 |
| 498 |
ABDOMINAL TENDERNESS |
1 |
0.0002 |
| 499 |
PNEUMONIA ASPIRATION |
5 |
0.0002 |
| 500 |
SPINAL FRACTURE |
4 |
0.0002 |
| 501 |
LACRIMATION INCREASED |
6 |
0.0002 |
| 502 |
CORONARY ARTERY DISEASE |
6 |
0.0002 |
| 503 |
BLOOD COUNT ABNORMAL |
3 |
0.0002 |
| 504 |
TOXIC EPIDERMAL NECROLYSIS |
3 |
0.0002 |
| 505 |
EYELID PTOSIS |
2 |
0.0002 |
| 506 |
DRUG LEVEL DECREASED |
2 |
0.0002 |
| 507 |
TOOTH ABSCESS |
2 |
0.0002 |
| 508 |
ATRIAL FIBRILLATION |
19 |
0.0002 |
| 509 |
EYE PAIN |
11 |
0.0002 |
| 510 |
TEMPERATURE INTOLERANCE |
2 |
0.0002 |
| 511 |
UNRESPONSIVE TO STIMULI |
5 |
0.0002 |
| 512 |
SKELETAL INJURY |
2 |
0.0002 |
| 513 |
EXPOSURE VIA SKIN CONTACT |
5 |
0.0002 |
| 514 |
VENTRICULAR EXTRASYSTOLES |
2 |
0.0002 |
| 515 |
EYE DISCHARGE |
2 |
0.0002 |
| 516 |
PANIC ATTACK |
7 |
0.0002 |
| 517 |
BRAIN FOG |
3 |
0.0002 |
| 518 |
MUSCLE SPASMS |
35 |
0.0002 |
| 519 |
FOLLICULITIS |
2 |
0.0002 |
| 520 |
INJECTION SITE DISCOMFORT |
2 |
0.0002 |
| 521 |
ARRHYTHMIA |
9 |
0.0002 |
| 522 |
BLOOD LACTIC ACID INCREASED |
1 |
0.0002 |
| 523 |
JOINT INJURY |
4 |
0.0002 |
| 524 |
SENSORY DISTURBANCE |
3 |
0.0002 |
| 525 |
HEREDITARY ANGIOEDEMA |
2 |
0.0002 |
| 526 |
NASOPHARYNGITIS |
34 |
0.0002 |
| 527 |
LIMB INJURY |
5 |
0.0002 |
| 528 |
PULMONARY THROMBOSIS |
2 |
0.0002 |
| 529 |
CONSTIPATION |
40 |
0.0002 |
| 530 |
DYSPEPSIA |
18 |
0.0002 |
| 531 |
MULTIPLE FRACTURES |
3 |
0.0002 |
| 532 |
SKIN LESION |
5 |
0.0002 |
| 533 |
ASTHENOPIA |
1 |
0.0002 |
| 534 |
THERAPEUTIC RESPONSE SHORTENED |
6 |
0.0002 |
| 535 |
PSYCHOMOTOR HYPERACTIVITY |
3 |
0.0002 |
| 536 |
VIRAL INFECTION |
6 |
0.0002 |
| 537 |
PROCEDURAL PAIN |
5 |
0.0002 |
| 538 |
NERVE INJURY |
2 |
0.0002 |
| 539 |
SEPSIS |
20 |
0.0002 |
| 540 |
PALPITATIONS |
21 |
0.0002 |
| 541 |
CHILLS |
21 |
0.0002 |
| 542 |
WOUND |
5 |
0.0002 |
| 543 |
MALNUTRITION |
2 |
0.0002 |
| 544 |
PULMONARY OEDEMA |
8 |
0.0002 |
| 545 |
ORAL PAIN |
4 |
0.0002 |
| 546 |
CELLULITIS |
9 |
0.0002 |
| 547 |
ANGIOPATHY |
1 |
0.0002 |
| 548 |
SKIN INFECTION |
2 |
0.0002 |
| 549 |
ACUTE PULMONARY OEDEMA |
1 |
0.0002 |
| 550 |
THERAPY NON-RESPONDER |
8 |
0.0002 |
| 551 |
FALL |
59 |
0.0002 |
| 552 |
HEART RATE IRREGULAR |
4 |
0.0002 |
| 553 |
COLECTOMY |
1 |
0.0002 |
| 554 |
CONTUSION |
17 |
0.0002 |
| 555 |
FLATULENCE |
10 |
0.0002 |
| 556 |
INTENTIONAL DOSE OMISSION |
5 |
0.0002 |
| 557 |
SCAB |
2 |
0.0002 |
| 558 |
MICTURITION URGENCY |
2 |
0.0002 |
| 559 |
INTERNAL HAEMORRHAGE |
2 |
0.0002 |
| 560 |
HYPERSOMNIA |
5 |
0.0002 |
| 561 |
NEOPLASM |
2 |
0.0002 |
| 562 |
PRODUCT SUBSTITUTION ISSUE |
10 |
0.0002 |
| 563 |
HYPOKALAEMIA |
8 |
0.0002 |
| 564 |
BLOOD URIC ACID INCREASED |
1 |
0.0002 |
| 565 |
PERICARDIAL EFFUSION |
4 |
0.0002 |
| 566 |
ASTHENIA |
65 |
0.0002 |
| 567 |
DEVICE USE ERROR |
6 |
0.0002 |
| 568 |
GAIT DISTURBANCE |
33 |
0.0002 |
| 569 |
MUSCULOSKELETAL PAIN |
9 |
0.0002 |
| 570 |
DYSSTASIA |
5 |
0.0002 |
| 571 |
BURNING SENSATION |
12 |
0.0002 |
| 572 |
CHRONIC KIDNEY DISEASE |
13 |
0.0002 |
| 573 |
BONE PAIN |
10 |
0.0002 |
| 574 |
SURGERY |
10 |
0.0002 |
| 575 |
COLD SWEAT |
3 |
0.0002 |
| 576 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
3 |
0.0002 |
| 577 |
TACHYCARDIA |
15 |
0.0002 |
| 578 |
CATARACT OPERATION |
1 |
0.0002 |
| 579 |
WEIGHT DECREASED |
47 |
0.0002 |
| 580 |
HYPERLIPIDAEMIA |
2 |
0.0002 |
| 581 |
GOUT |
3 |
0.0002 |
| 582 |
BLOOD PRESSURE FLUCTUATION |
4 |
0.0002 |
| 583 |
DIZZINESS |
83 |
0.0002 |
| 584 |
ARTHRITIS |
13 |
0.0002 |
| 585 |
NOCTURIA |
2 |
0.0002 |
| 586 |
PLEURAL EFFUSION |
10 |
0.0002 |
| 587 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
9 |
0.0002 |
| 588 |
BACK PAIN |
38 |
0.0002 |
| 589 |
MUSCLE SPASTICITY |
2 |
0.0002 |
| 590 |
CARDIOMEGALY |
2 |
0.0002 |
| 591 |
SMALL INTESTINAL OBSTRUCTION |
2 |
0.0002 |
| 592 |
ABNORMAL WEIGHT GAIN |
2 |
0.0002 |
| 593 |
NECK PAIN |
9 |
0.0002 |
| 594 |
MIDDLE INSOMNIA |
3 |
0.0002 |
| 595 |
BONE DENSITY DECREASED |
5 |
0.0002 |
| 596 |
PAIN IN EXTREMITY |
47 |
0.0002 |
| 597 |
PHOTOPHOBIA |
3 |
0.0002 |
| 598 |
BLOOD SODIUM DECREASED |
3 |
0.0002 |
| 599 |
BLEPHAROSPASM |
1 |
0.0002 |
| 600 |
BRAIN OEDEMA |
2 |
0.0002 |
| 601 |
PRODUCT COMPLAINT |
4 |
0.0002 |
| 602 |
PRODUCT DOSE OMISSION ISSUE |
46 |
0.0002 |
| 603 |
ANOREXIA |
2 |
0.0002 |
| 604 |
ERUCTATION |
3 |
0.0002 |
| 605 |
DIPLOPIA |
4 |
0.0002 |
| 606 |
HAEMORRHOIDS |
3 |
0.0002 |
| 607 |
AMNESIA |
10 |
0.0002 |
| 608 |
PLATELET COUNT INCREASED |
2 |
0.0002 |
| 609 |
PRODUCT DOSE OMISSION |
10 |
0.0002 |
| 610 |
ASPERGILLUS INFECTION |
1 |
0.0002 |
| 611 |
BEDRIDDEN |
2 |
0.0002 |
| 612 |
CORONAVIRUS INFECTION |
1 |
0.0002 |
| 613 |
INFUSION RELATED REACTION |
10 |
0.0002 |
| 614 |
BLOOD PRESSURE DECREASED |
10 |
0.0002 |
| 615 |
CARDIAC FAILURE ACUTE |
1 |
0.0001 |
| 616 |
AGITATION |
11 |
0.0001 |
| 617 |
HYPOTENSION |
30 |
0.0001 |
| 618 |
GASTROOESOPHAGEAL REFLUX DISEASE |
12 |
0.0001 |
| 619 |
CONFUSIONAL STATE |
24 |
0.0001 |
| 620 |
COLITIS ISCHAEMIC |
1 |
0.0001 |
| 621 |
MALAISE |
65 |
0.0001 |
| 622 |
FEEDING DISORDER |
3 |
0.0001 |
| 623 |
THROAT TIGHTNESS |
4 |
0.0001 |
| 624 |
BLINDNESS |
6 |
0.0001 |
| 625 |
FEELING HOT |
9 |
0.0001 |
| 626 |
RASH ERYTHEMATOUS |
7 |
0.0001 |
| 627 |
ACUTE HEPATIC FAILURE |
2 |
0.0001 |
| 628 |
LUNG NEOPLASM MALIGNANT |
6 |
0.0001 |
| 629 |
CORONARY ARTERY OCCLUSION |
2 |
0.0001 |
| 630 |
GASTRIC DISORDER |
5 |
0.0001 |
| 631 |
PERIPHERAL COLDNESS |
2 |
0.0001 |
| 632 |
HYPERSENSITIVITY |
27 |
0.0001 |
| 633 |
UNEVALUABLE EVENT |
11 |
0.0001 |
| 634 |
GASTROINTESTINAL DISORDER |
13 |
0.0001 |
| 635 |
INFECTION |
21 |
0.0001 |
| 636 |
TOOTH LOSS |
3 |
0.0001 |
| 637 |
BLOOD PRESSURE INCREASED |
22 |
0.0001 |
| 638 |
NEOPLASM PROGRESSION |
5 |
0.0001 |
| 639 |
COORDINATION ABNORMAL |
2 |
0.0001 |
| 640 |
MASS |
2 |
0.0001 |
| 641 |
WEIGHT INCREASED |
32 |
0.0001 |
| 642 |
CARPAL TUNNEL SYNDROME |
2 |
0.0001 |
| 643 |
DEFAECATION URGENCY |
1 |
0.0001 |
| 644 |
HEART RATE DECREASED |
5 |
0.0001 |
| 645 |
DEVICE OCCLUSION |
2 |
0.0001 |
| 646 |
SLEEP DISORDER |
10 |
0.0001 |
| 647 |
FATIGUE |
110 |
0.0001 |
| 648 |
DIALYSIS |
2 |
0.0001 |
| 649 |
EATING DISORDER |
3 |
0.0001 |
| 650 |
MUSCULAR WEAKNESS |
16 |
0.0001 |
| 651 |
HEADACHE |
88 |
0.0001 |
| 652 |
LETHARGY |
8 |
0.0001 |
| 653 |
ELECTROCARDIOGRAM QT PROLONGED |
5 |
0.0001 |
| 654 |
PRURITUS GENERALISED |
3 |
0.0001 |
| 655 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
3 |
0.0001 |
| 656 |
HYPERTENSION |
29 |
0.0001 |
| 657 |
DRUG INEFFECTIVE |
180 |
0.0001 |
| 658 |
ACUTE MYOCARDIAL INFARCTION |
4 |
0.0001 |
| 659 |
DRUG EFFECT LESS THAN EXPECTED |
2 |
0.0001 |
| 660 |
STEVENS-JOHNSON SYNDROME |
3 |
0.0001 |
| 661 |
ABDOMINAL DISTENSION |
14 |
0.0001 |
| 662 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
6 |
0.0001 |
| 663 |
SPEECH DISORDER |
7 |
0.0001 |
| 664 |
ANXIETY |
38 |
0.0001 |
| 665 |
DECREASED APPETITE |
31 |
0.0001 |
| 666 |
APHASIA |
4 |
0.0001 |
| 667 |
PRODUCT AVAILABILITY ISSUE |
3 |
0.0001 |
| 668 |
GASTROINTESTINAL HAEMORRHAGE |
11 |
0.0001 |
| 669 |
NEPHROLITHIASIS |
6 |
0.0001 |
| 670 |
BOWEL MOVEMENT IRREGULARITY |
1 |
0.0001 |
| 671 |
SKIN DISCOLOURATION |
6 |
0.0001 |
| 672 |
DEVICE RELATED INFECTION |
2 |
0.0001 |
| 673 |
SYNCOPE |
13 |
0.0001 |
| 674 |
ATRIOVENTRICULAR BLOCK |
1 |
0.0001 |
| 675 |
APNOEA |
1 |
0.0001 |
| 676 |
DEVICE MALFUNCTION |
9 |
0.0001 |
| 677 |
DEHYDRATION |
17 |
0.0001 |
| 678 |
BALANCE DISORDER |
11 |
0.0001 |
| 679 |
AFFECTIVE DISORDER |
1 |
0.0001 |
| 680 |
PRODUCT USE COMPLAINT |
2 |
0.0001 |
| 681 |
HYPOAESTHESIA |
19 |
0.0001 |
| 682 |
ANAPHYLACTIC REACTION |
7 |
0.0001 |
| 683 |
OCULAR HYPERAEMIA |
6 |
0.0001 |
| 684 |
PNEUMOTHORAX |
2 |
0.0001 |
| 685 |
DRUG INTERACTION |
20 |
0.0001 |
| 686 |
BLOOD ALBUMIN DECREASED |
1 |
0.0001 |
| 687 |
MIGRAINE |
12 |
0.0001 |
| 688 |
COVID-19 |
22 |
0.0001 |
| 689 |
ATRIAL FLUTTER |
1 |
0.0001 |
| 690 |
CONDITION AGGRAVATED |
38 |
0.0001 |
| 691 |
THROMBOSIS |
10 |
0.0001 |
| 692 |
HYPERHIDROSIS |
16 |
0.0001 |
| 693 |
UNDERDOSE |
9 |
0.0001 |
| 694 |
DYSKINESIA |
5 |
0.0001 |
| 695 |
DEVICE ISSUE |
11 |
0.0001 |
| 696 |
NAUSEA |
97 |
0.0001 |
| 697 |
VENTRICULAR TACHYCARDIA |
2 |
0.0001 |
| 698 |
ACUTE CORONARY SYNDROME |
1 |
0.0001 |
| 699 |
URINARY RETENTION |
4 |
0.0001 |
| 700 |
GAIT INABILITY |
4 |
0.0001 |
| 701 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
2 |
0.0001 |
| 702 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
3 |
0.0001 |
| 703 |
TYPE 2 DIABETES MELLITUS |
4 |
0.0001 |
| 704 |
OSTEOARTHRITIS |
5 |
0.0001 |
| 705 |
HYPOPHAGIA |
3 |
0.0001 |
| 706 |
THERAPY CESSATION |
6 |
0.0001 |
| 707 |
FEELING ABNORMAL |
28 |
0.0001 |
| 708 |
HAEMATURIA |
4 |
0.0001 |
| 709 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
2 |
0.0001 |
| 710 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
21 |
0.0001 |
| 711 |
IRRITABILITY |
7 |
0.0001 |
| 712 |
RECTAL HAEMORRHAGE |
5 |
0.0001 |
| 713 |
CARDIAC OPERATION |
1 |
0.0001 |
| 714 |
RASH GENERALISED |
3 |
0.0001 |
| 715 |
HAEMATOMA |
3 |
0.0001 |
| 716 |
MULTI-ORGAN FAILURE |
2 |
0.0001 |
| 717 |
EMOTIONAL DISTRESS |
14 |
0.0001 |
| 718 |
PAIN |
71 |
0.0001 |
| 719 |
ARTHRALGIA |
48 |
0.0001 |
| 720 |
STOMATITIS |
7 |
0.0001 |
| 721 |
DISCOMFORT |
7 |
0.0001 |
| 722 |
LOCAL SWELLING |
2 |
0.0001 |
| 723 |
JOINT STIFFNESS |
3 |
0.0001 |
| 724 |
NEUROTOXICITY |
2 |
0.0001 |
| 725 |
GASTRITIS |
3 |
0.0001 |
| 726 |
PANCREATITIS |
6 |
0.0001 |
| 727 |
VISUAL IMPAIRMENT |
14 |
0.0001 |
| 728 |
DIABETES MELLITUS INADEQUATE CONTROL |
2 |
0.0001 |
| 729 |
RENAL FAILURE |
15 |
0.0001 |
| 730 |
DRUG ERUPTION |
2 |
0.0001 |
| 731 |
EAR INFECTION |
3 |
0.0001 |
| 732 |
PRODUCT USE ISSUE |
21 |
0.0001 |
| 733 |
DIARRHOEA |
72 |
0.0001 |
| 734 |
FEAR |
3 |
0.0001 |
| 735 |
ANAL INCONTINENCE |
1 |
0.0001 |
| 736 |
RASH PRURITIC |
6 |
0.0001 |
| 737 |
TOOTHACHE |
2 |
0.0001 |
| 738 |
PALLOR |
3 |
0.0001 |
| 739 |
MOOD ALTERED |
3 |
0.0001 |
| 740 |
LOWER RESPIRATORY TRACT INFECTION |
5 |
0.0001 |
| 741 |
TREATMENT NONCOMPLIANCE |
6 |
0.0001 |
| 742 |
RESTLESSNESS |
4 |
0.0001 |
| 743 |
LOSS OF CONSCIOUSNESS |
14 |
0.0001 |
| 744 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
2 |
0.0001 |
| 745 |
BRAIN NEOPLASM |
1 |
0.0001 |
| 746 |
TINNITUS |
5 |
0.0001 |
| 747 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
1 |
0.0001 |
| 748 |
ABNORMAL DREAMS |
3 |
0.0001 |
| 749 |
HEPATIC STEATOSIS |
2 |
0.0001 |
| 750 |
DEMENTIA |
3 |
0.0001 |
| 751 |
RENAL DISORDER |
5 |
0.0001 |
| 752 |
ACCIDENTAL EXPOSURE TO PRODUCT |
11 |
0.0001 |
| 753 |
SKIN EXFOLIATION |
9 |
0.0001 |
| 754 |
HYPONATRAEMIA |
6 |
0.0001 |
| 755 |
DYSARTHRIA |
4 |
0.0001 |
| 756 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
3 |
0.0001 |
| 757 |
FRACTURE |
2 |
0.0001 |
| 758 |
COLITIS |
4 |
0.0001 |
| 759 |
FOOT FRACTURE |
2 |
0.0001 |
| 760 |
GASTRIC ULCER |
2 |
0.0001 |
| 761 |
INTERNATIONAL NORMALISED RATIO INCREASED |
3 |
0.0001 |
| 762 |
MUSCULOSKELETAL DISORDER |
2 |
0.0001 |
| 763 |
RED BLOOD CELL COUNT DECREASED |
3 |
0.0001 |
| 764 |
INCREASED APPETITE |
2 |
0.0001 |
| 765 |
HERPES ZOSTER |
6 |
0.0001 |
| 766 |
EYE IRRITATION |
6 |
0.0001 |
| 767 |
SEROTONIN SYNDROME |
2 |
0.0001 |
| 768 |
AFFECT LABILITY |
1 |
0.0001 |
| 769 |
PRESCRIBED OVERDOSE |
2 |
0.0001 |
| 770 |
DYSTONIA |
2 |
0.0001 |
| 771 |
AUTOIMMUNE DISORDER |
1 |
0.0001 |
| 772 |
KIDNEY INFECTION |
2 |
0.0001 |
| 773 |
BODY TEMPERATURE DECREASED |
1 |
0.0001 |
| 774 |
INSOMNIA |
27 |
0.0001 |
| 775 |
ABDOMINAL DISCOMFORT |
17 |
0.0001 |
| 776 |
URINARY INCONTINENCE |
3 |
0.0001 |
| 777 |
PYREXIA |
35 |
0.0001 |
| 778 |
DISORIENTATION |
4 |
0.0001 |
| 779 |
RASH |
44 |
0.0001 |
| 780 |
HAEMATOCRIT DECREASED |
2 |
0.0001 |
| 781 |
BLADDER DISORDER |
1 |
0.0001 |
| 782 |
BRAIN INJURY |
1 |
0.0001 |
| 783 |
CYTOKINE RELEASE SYNDROME |
2 |
0.0001 |
| 784 |
ANAEMIA |
19 |
0.0001 |
| 785 |
JOINT SWELLING |
12 |
0.0001 |
| 786 |
PRODUCT PHYSICAL ISSUE |
2 |
0.0001 |
| 787 |
INJECTION SITE RASH |
3 |
0.0001 |
| 788 |
HAEMOGLOBIN DECREASED |
10 |
0.0001 |
| 789 |
INJECTION SITE WARMTH |
2 |
0.0001 |
| 790 |
ABDOMINAL PAIN UPPER |
20 |
0.0001 |
| 791 |
LIMB DISCOMFORT |
3 |
0.0001 |
| 792 |
DRUG DOSE OMISSION |
16 |
0.0001 |
| 793 |
RHABDOMYOLYSIS |
4 |
0.0001 |
| 794 |
DRUG-INDUCED LIVER INJURY |
3 |
0.0001 |
| 795 |
MOUTH ULCERATION |
2 |
0.0001 |
| 796 |
MEMORY IMPAIRMENT |
13 |
0.0001 |
| 797 |
ABDOMINAL PAIN |
22 |
0.0001 |
| 798 |
CLOSTRIDIUM DIFFICILE COLITIS |
1 |
0.0001 |
| 799 |
RENAL FAILURE ACUTE |
4 |
0.0001 |
| 800 |
DEATH |
81 |
0.0001 |
| 801 |
HYPOTHYROIDISM |
3 |
0.0001 |
| 802 |
METABOLIC ACIDOSIS |
3 |
0.0001 |
| 803 |
BREAST PAIN |
1 |
0.0001 |
| 804 |
MOVEMENT DISORDER |
3 |
0.0001 |
| 805 |
HYPOACUSIS |
4 |
0.0001 |
| 806 |
ALTERED STATE OF CONSCIOUSNESS |
2 |
0.0001 |
| 807 |
DEVICE LEAKAGE |
4 |
0.0001 |
| 808 |
SWELLING FACE |
6 |
0.0001 |
| 809 |
BIPOLAR DISORDER |
1 |
0.0001 |
| 810 |
SEPTIC SHOCK |
4 |
0.0001 |
| 811 |
BLOOD CREATININE INCREASED |
6 |
0.0001 |
| 812 |
CLOSTRIDIUM DIFFICILE INFECTION |
2 |
0.0001 |
| 813 |
ACUTE KIDNEY INJURY |
14 |
0.0001 |
| 814 |
PRODUCT STORAGE ERROR |
8 |
0.0001 |
| 815 |
EYE DISORDER |
3 |
0.0001 |
| 816 |
PRURITUS |
35 |
0.0001 |
| 817 |
ANGIOEDEMA |
4 |
0.0001 |
| 818 |
SKIN DISORDER |
3 |
0.0001 |
| 819 |
VOMITING |
42 |
0.0001 |
| 820 |
RASH PAPULAR |
2 |
0.0001 |
| 821 |
THERAPEUTIC RESPONSE UNEXPECTED |
4 |
0.0001 |
| 822 |
BLOOD CALCIUM DECREASED |
1 |
0.0001 |
| 823 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
18 |
0.0001 |
| 824 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
3 |
0.0001 |
| 825 |
ANGER |
3 |
0.0001 |
| 826 |
CHROMATURIA |
2 |
0.0001 |
| 827 |
FLUSHING |
9 |
0.0001 |
| 828 |
CHOLECYSTECTOMY |
1 |
0.0001 |
| 829 |
CARDIAC FAILURE |
7 |
0.0001 |
| 830 |
ADVERSE EVENT |
8 |
0.0001 |
| 831 |
MUSCLE TWITCHING |
2 |
0.0001 |
| 832 |
NIGHTMARE |
3 |
0.0001 |
| 833 |
HAEMORRHAGE |
9 |
0.0001 |
| 834 |
RASH MACULAR |
3 |
0.0001 |
| 835 |
HYPERKALAEMIA |
3 |
0.0001 |
| 836 |
CARDIAC DISORDER |
8 |
0.0001 |
| 837 |
CARDIAC ARREST |
7 |
0.0001 |
| 838 |
COVID-19 PNEUMONIA |
1 |
0.0001 |
| 839 |
BLOOD IRON DECREASED |
1 |
0.0001 |
| 840 |
ATAXIA |
1 |
0.0001 |
| 841 |
THERAPY INTERRUPTED |
6 |
0.0001 |
| 842 |
DEPRESSION |
19 |
0.0001 |
| 843 |
BLOOD GLUCOSE DECREASED |
4 |
0.0001 |
| 844 |
MENTAL IMPAIRMENT |
2 |
0.0001 |
| 845 |
BURSITIS |
1 |
0.0001 |
| 846 |
DRY SKIN |
11 |
0.0001 |
| 847 |
ADRENAL INSUFFICIENCY |
1 |
0.0001 |
| 848 |
HYPERGLYCAEMIA |
3 |
0.0001 |
| 849 |
ILL-DEFINED DISORDER |
5 |
0.0001 |
| 850 |
ENCEPHALOPATHY |
2 |
0.0001 |
| 851 |
ABASIA |
2 |
0.0001 |
| 852 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
2 |
0.0001 |
| 853 |
INTENTIONAL PRODUCT USE ISSUE |
7 |
0.0001 |
| 854 |
ABDOMINAL PAIN LOWER |
2 |
0.0001 |
| 855 |
HAEMATEMESIS |
2 |
0.0001 |
| 856 |
ERYTHEMA |
16 |
0.0001 |
| 857 |
GENERAL PHYSICAL HEALTH DETERIORATION |
9 |
0.0001 |
| 858 |
PHARMACEUTICAL PRODUCT COMPLAINT |
2 |
0.0001 |
| 859 |
OFF LABEL USE |
67 |
0.0001 |
| 860 |
SUICIDAL IDEATION |
7 |
0.0001 |
| 861 |
MYALGIA |
13 |
0.0001 |
| 862 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
2 |
0.0001 |
| 863 |
PARAESTHESIA |
12 |
0.0001 |
| 864 |
ANKYLOSING SPONDYLITIS |
1 |
0.0001 |
| 865 |
ASPARTATE AMINOTRANSFERASE INCREASED |
4 |
0.0001 |
| 866 |
BREAST CANCER FEMALE |
2 |
0.0001 |
| 867 |
INJECTION SITE PRURITUS |
5 |
0.0001 |
| 868 |
BLOOD GLUCOSE INCREASED |
14 |
0.0001 |
| 869 |
PAIN OF SKIN |
2 |
0.0001 |
| 870 |
DISTURBANCE IN ATTENTION |
4 |
0.0001 |
| 871 |
EXTRA DOSE ADMINISTERED |
3 |
0.0001 |
| 872 |
WHITE BLOOD CELL COUNT DECREASED |
8 |
0.0001 |
| 873 |
NEUROPATHY PERIPHERAL |
7 |
0.0001 |
| 874 |
PNEUMONITIS |
2 |
0.0001 |
| 875 |
INFLUENZA LIKE ILLNESS |
6 |
0.0001 |
| 876 |
CENTRAL NERVOUS SYSTEM LESION |
1 |
0.0001 |
| 877 |
DIVERTICULITIS |
2 |
0.0001 |
| 878 |
FEELING COLD |
2 |
0.0001 |
| 879 |
CARDIO-RESPIRATORY ARREST |
3 |
0.0001 |
| 880 |
URTICARIA |
12 |
0.0001 |
| 881 |
HOSPITALISATION |
11 |
0.0001 |
| 882 |
RENAL IMPAIRMENT |
6 |
0.0001 |
| 883 |
BLOOD TEST ABNORMAL |
1 |
0.0001 |
| 884 |
BLINDNESS UNILATERAL |
1 |
0.0001 |
| 885 |
CEREBROVASCULAR ACCIDENT |
12 |
0.0001 |
| 886 |
RHEUMATOID ARTHRITIS |
8 |
0.0001 |
| 887 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
5 |
0.0001 |
| 888 |
MOBILITY DECREASED |
5 |
0.0001 |
| 889 |
ACCIDENTAL UNDERDOSE |
1 |
0.0001 |
| 890 |
COMPLICATION ASSOCIATED WITH DEVICE |
1 |
0.0001 |
| 891 |
MYOCARDIAL INFARCTION |
12 |
0.0001 |
| 892 |
NEEDLE ISSUE |
2 |
0.0001 |
| 893 |
MUSCULOSKELETAL STIFFNESS |
6 |
0.0001 |
| 894 |
LABORATORY TEST ABNORMAL |
2 |
0.0001 |
| 895 |
CARDIOMYOPATHY |
1 |
0.0001 |
| 896 |
LIVER DISORDER |
3 |
0.0001 |
| 897 |
DISEASE PROGRESSION |
8 |
0.0001 |
| 898 |
RENAL INJURY |
2 |
0.0001 |
| 899 |
COLON CANCER |
1 |
0.0001 |
| 900 |
BONE LOSS |
1 |
0.0001 |
| 901 |
HALLUCINATION |
5 |
0.0001 |
| 902 |
HOT FLUSH |
5 |
0.0001 |
| 903 |
HEPATIC FAILURE |
2 |
0.0001 |
| 904 |
THERAPEUTIC RESPONSE DECREASED |
4 |
0.0001 |
| 905 |
PLATELET COUNT DECREASED |
7 |
0.0001 |
| 906 |
VERTIGO |
4 |
0.0001 |
| 907 |
SKIN IRRITATION |
3 |
0.0001 |
| 908 |
INJECTION SITE PAIN |
20 |
0.0001 |
| 909 |
ALANINE AMINOTRANSFERASE INCREASED |
4 |
0.0001 |
| 910 |
EMOTIONAL DISORDER |
2 |
0.0001 |
| 911 |
ANKLE FRACTURE |
1 |
0.0001 |
| 912 |
SOMNOLENCE |
13 |
0.0001 |
| 913 |
BASAL CELL CARCINOMA |
1 |
0.0001 |
| 914 |
CYANOSIS |
1 |
0.0001 |
| 915 |
COMA |
3 |
0.0001 |
| 916 |
CYSTITIS |
2 |
0.0001 |
| 917 |
ABSCESS |
1 |
0.0001 |
| 918 |
DRUG INTOLERANCE |
6 |
0.0001 |
| 919 |
NIGHT SWEATS |
2 |
0.0001 |
| 920 |
INTERSTITIAL LUNG DISEASE |
3 |
0.0001 |
| 921 |
DEEP VEIN THROMBOSIS |
4 |
0.0001 |
| 922 |
INCORRECT DOSE ADMINISTERED |
14 |
0.0001 |
| 923 |
OSTEONECROSIS |
2 |
0.0001 |
| 924 |
NO ADVERSE EVENT |
11 |
0.0001 |
| 925 |
SEIZURE |
7 |
0.0001 |
| 926 |
VISUAL ACUITY REDUCED |
2 |
0.0001 |
| 927 |
LEUKOPENIA |
3 |
0.0001 |
| 928 |
INFLAMMATION |
3 |
0.0001 |
| 929 |
ECZEMA |
3 |
0.0001 |
| 930 |
DERMATITIS ATOPIC |
3 |
0.0001 |
| 931 |
BRADYCARDIA |
3 |
0.0001 |
| 932 |
INJECTION SITE ERYTHEMA |
7 |
0.0001 |
| 933 |
ALOPECIA |
11 |
0.0001 |
| 934 |
PRODUCT ADHESION ISSUE |
2 |
0.0001 |
| 935 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
2 |
0.0001 |
| 936 |
CEREBRAL HAEMORRHAGE |
2 |
0.0001 |
| 937 |
ACCIDENTAL OVERDOSE |
2 |
0.0001 |
| 938 |
INJECTION SITE MASS |
2 |
0.0001 |
| 939 |
THROMBOCYTOPENIA |
6 |
0.0001 |
| 940 |
SWELLING |
5 |
0.0001 |
| 941 |
BLISTER |
3 |
0.0001 |
| 942 |
INJECTION SITE SWELLING |
4 |
0.0001 |
| 943 |
BLOOD PRESSURE SYSTOLIC INCREASED |
1 |
0.0001 |
| 944 |
OVERDOSE |
11 |
0.0001 |
| 945 |
DEVICE BREAKAGE |
2 |
0.0000 |
| 946 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 947 |
WITHDRAWAL SYNDROME |
2 |
0.0000 |
| 948 |
DEVICE DISLOCATION |
2 |
0.0000 |
| 949 |
DEVICE DIFFICULT TO USE |
3 |
0.0000 |
| 950 |
NEOPLASM MALIGNANT |
3 |
0.0000 |
| 951 |
INJECTION SITE REACTION |
3 |
0.0000 |
| 952 |
BLOOD CHOLESTEROL INCREASED |
2 |
0.0000 |
| 953 |
COGNITIVE DISORDER |
2 |
0.0000 |
| 954 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
2 |
0.0000 |
| 955 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
3 |
0.0000 |
| 956 |
DISEASE RECURRENCE |
2 |
0.0000 |
| 957 |
SKIN BURNING SENSATION |
3 |
0.0000 |
| 958 |
MULTIPLE SCLEROSIS |
2 |
0.0000 |
| 959 |
HYPOGLYCAEMIA |
2 |
0.0000 |
| 960 |
CEREBRAL INFARCTION |
1 |
0.0000 |
| 961 |
ACNE |
3 |
0.0000 |
| 962 |
CARDIOVASCULAR DISORDER |
1 |
0.0000 |
| 963 |
DIABETES MELLITUS |
3 |
0.0000 |
| 964 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 965 |
DRUG DOSE OMISSION BY DEVICE |
3 |
0.0000 |
| 966 |
DEAFNESS |
1 |
0.0000 |
| 967 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 968 |
HAEMATOCHEZIA |
2 |
0.0000 |
| 969 |
CONVULSION |
2 |
0.0000 |
| 970 |
ANGINA PECTORIS |
1 |
0.0000 |
| 971 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
1 |
0.0000 |
| 972 |
DRUG WITHDRAWAL SYNDROME |
3 |
0.0000 |
| 973 |
ASCITES |
1 |
0.0000 |
| 974 |
ADVERSE DRUG REACTION |
3 |
0.0000 |
| 975 |
PULMONARY EMBOLISM |
3 |
0.0000 |
| 976 |
CHOLELITHIASIS |
1 |
0.0000 |
| 977 |
HEPATIC ENZYME INCREASED |
2 |
0.0000 |
| 978 |
MALIGNANT NEOPLASM PROGRESSION |
3 |
0.0000 |
| 979 |
DELIRIUM |
1 |
0.0000 |
| 980 |
INJURY |
2 |
0.0000 |
| 981 |
CRYING |
1 |
0.0000 |
| 982 |
ABNORMAL BEHAVIOUR |
1 |
0.0000 |
| 983 |
INJECTION SITE BRUISING |
2 |
0.0000 |
| 984 |
PROSTATE CANCER |
2 |
0.0000 |
| 985 |
PSORIASIS |
3 |
0.0000 |
| 986 |
MATERNAL EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 987 |
COLITIS ULCERATIVE |
1 |
0.0000 |
| 988 |
BREAST CANCER |
2 |
0.0000 |
| 989 |
DEPENDENCE |
1 |
0.0000 |
| 990 |
TOXICITY TO VARIOUS AGENTS |
3 |
0.0000 |
| 991 |
NEUTROPENIA |
2 |
0.0000 |
| 992 |
COMPLETED SUICIDE |
1 |
0.0000 |